IP Library Granted Patent US 11,935,657
Granted Patent B2
US 11,935,657 · App. 17/408,698 · Granted Mar 19, 2024

System and method for a digital consumer medical wallet and storehouse

Inventors: Jovan Hutton Pulitzer (Frisco, TX); Henry Joseph Legere, III (Austin, TX)
Assignee: Reliant Immune Diagnostics, Inc.
G16H50/30G01N33/5302G01N33/54388G01N33/54389G01N33/54391G06Q30/0267G06Q30/0269G06T7/0014G16H10/65H04N23/64G01N2333/59G01N2333/9513G06F3/0482G06F2218/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,935,657
App. No.
17/408,698
Granted
Mar 19, 2024
Kind
B2
Abstract

A system and method are provided for collection and testing of a biologic sample. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects further include presenting advertisements and other messages to users through a mobile application operating on a mobile device. These aspects take into account the results of the self-diagnostic test and present different advertisements to the user based on the results of the test.

Claims (66)

1. A system, comprising:

a mobile device; and

a server disposed on a network, the server configured to:

receive, from the mobile device, an image of at least one medical product;

identify the at least one medical product in the image;

populate a database with user medical supply inventory information including information associated with the identified at least one medical product;

transmit at least a portion of the user medical supply inventory information to a healthcare provider;

receive, from the mobile device, loyalty point information;

populate the database with the loyalty point information in association with a user;

receive a request from a retailer for the loyalty point information; and

transmit the loyalty point information to the retailer.

2. The system of claim 1 , wherein the server is further configured to receive, from the mobile device, diagnostic test results and user information associated with a testing device.

3. The system of claim 2 , wherein the server is further configured to:

determine if the diagnostic test results include a positive result;

present, if the diagnostic test results are positive, a telemedicine initiation option on a screen of the mobile device;

determine whether the telemedicine initiation option is selected;

send the diagnostic test results from the server to a telemedicine provider;

send additional medical history information to the telemedicine provider; and initiate a telemedicine conference with the telemedicine provider.

4. The system of claim 3 , wherein the server is further configured to:

receive, over the network, a notification relating to an issued prescription; and communicate information relating to the issued prescription over the network to a pharmacy.

5. The system of claim 2 , wherein the testing device includes a plurality of immunoassay test strips.

6. The system of claim 5 , wherein a test line of one of the plurality of immunoassay test strips includes Zika virus antigen and a test line of another one of the plurality of immunoassay test strips includes an antibody suitable for binding with hCG.

7. The system of claim 5 , wherein the mobile device includes a camera, a viewing screen, and a software application stored thereon, wherein the software application provides executable instructions that, when executed, cause the mobile device to:

initiate operation of the camera of the mobile device;

present on the viewing screen of the mobile device an alignment graphic to be aligned with an alignment target of the testing device;

detect when an alignment of the alignment graphic and the alignment target has taken place;

capture an image of the testing device;

process the image to determine pixel count and line intensity of a test line of each of the plurality of immunoassay test strips;

compare one or more results of processing the image to a control for each test line of each of the plurality of immunoassay test strips; and

present the diagnostic test results on the viewing screen.

8. The system of claim 7 , wherein the control is a dataset from previously conducted tests stored on the database and accessed by the software application.

9. The system of claim 7 , wherein the diagnostic test results include a quantitative result.

10. The system of claim 9 , wherein the quantitative result includes a reaction rating.

11. A method, comprising:

receiving, by a server from a mobile device, an image of at least one medical product;

identifying, by the server, the at least one medical product in the image;

populating, by the server, a database with user medical supply inventory information including information associated with the identified at least one medical product;

transmitting, by the server, at least a portion of the user medical supply inventory information to a healthcare provider;

receiving, by the server from the mobile device, loyalty point information;

populating the database with the loyalty point information in association with a user;

receiving a request from a retailer for the loyalty point information; and

transmitting the loyalty point information to the retailer.

12. The method of claim 11 , further comprising receiving by the server disposed on a network, from the mobile device, diagnostic test results and user information associated with a testing device.

13. The method of claim 12 , further comprising:

determining, by the server, if the diagnostic test results include a positive result;

presenting if the diagnostic test results are positive, a telemedicine initiation option on a screen of the mobile device;

determining whether the telemedicine initiation option is selected;

sending, by the server, the diagnostic test results from the server to a telemedicine provider;

sending, by the server, additional medical history information to the telemedicine provider; and

initiating, by the server, a telemedicine conference with the telemedicine provider.

14. The method of claim 13 , further comprising:

receiving, by the server over the network, a notification relating to an issued prescription; and

communicating information relating to the issued prescription over the network to a pharmacy.

15. The method of claim 12 , wherein the testing device includes a plurality of immunoassay test strips.

16. The method of claim 15 , wherein a test line of one of the plurality of immunoassay test strips includes Zika virus antigen and a test line of another one of the plurality of immunoassay test strips includes an antibody suitable for binding with hCG.

17. The method of claim 15 , wherein the mobile device includes a camera, a viewing screen, and a software application stored thereon, and the method further comprising:

initiating operation of the camera of the mobile device;

presenting on the viewing screen of the mobile device an alignment graphic to be aligned with an alignment target of the testing device;

detecting, by the mobile device, when an alignment of the alignment graphic and the alignment target has taken place;

capturing, by the mobile device, an image of the testing device;

processing, by the mobile device, the image to determine pixel count and line intensity of a test line of each of the plurality of immunoassay test strips;

comparing, by the mobile device, one or more results of processing the image to a control for each test line of each of the plurality of immunoassay test strips; and

presenting the diagnostic test results on the viewing screen of the mobile device.

18. The method of claim 17 , wherein the control is a dataset from previously conducted tests stored on the database and accessed by the software application.

19. The method of claim 17 , wherein the diagnostic test results include a quantitative result.

20. The method of claim 19 , wherein the quantitative result includes a reaction rating.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2021
From: PULITZER, JOVAN HUTTON; LEGERE, HENRY JOSEPH, III
To: RELIANT IMMUNE DIAGNOSTICS, INC.
Reel/Frame 057255/0450 →
Continuity (6)
Continuation 16137204 · Sep 20, 2018
Continuation In Part 15804990 · Nov 6, 2017
Continuation In Part 15295398 · Oct 17, 2016
Provisional Application 62566598 · Oct 2, 2017
Provisional Application 62419382 · Nov 8, 2016
Related Publication 20210383930A1 · Dec 9, 2021